Evidence map›Paper›PMID 23011354›Full record

ArticleDiabetologia2013

In vitro scan for enhancers at the TCF7L2 locus.

D Savic, S Y Park, K A Bailey, G I Bell, M A Nobrega

Open access · greenAbstract read
In one paragraph

Article in Diabetologia, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. The Role ofDiabetes · 2021
    Review
  4. Article
  5. The rs7903146 Variant in theDiabetes care · 2017
    Article
  6. Article
  7. Article
  8. Article
  9. Redundant enhancers and causal variants in the TCF7L2 gene.European journal of human genetics : EJHG · 2014
    Article
  10. Article
  11. Enhancers: five essential questions.Nature reviews. Genetics · 2013
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

D SavicDepartment of Human Genetics, University of Chicago, 920 E. 58th St, CLSC 319A, Chicago, IL 60637, USA.
S Y Park
K A Bailey
G I Bell
M A Nobrega
University of Chicago · US

Funding

TRANSGENIC COREP60DK020595 · NIDDK · UNIVERSITY OF CHICAGO · PI BELL, GRAEME I · 1985 to 2012
$25.5M
Pilot and Feasibility ProgramP30DK020595 · NIDDK · UNIVERSITY OF CHICAGO · PI Matthew J Brady · 2013 to 2026
$20.9M
PREDOCTORAL TRAINING IN GENETICS AND REGULATIONT32GM007197 · NIGMS · UNIVERSITY OF CHICAGO · PI ROTHMAN-DENES, LUCIA B. B · 1985 to 2020
$17.0M
Generation and in vivo validation of cis-regulatory maps in eukaryotic genomesR01HG004428 · NHGRI · UNIVERSITY OF CHICAGO · PI NOBREGA, MARCELO A. · 2007 to 2009
$1.5M
Functional follow-up of the association between TCF7L2 and T2DR01DK093972 · NIDDK · UNIVERSITY OF CHICAGO · PI BELL, GRAEME I, NOBREGA, MARCELO A. · 2012 to 2014
$1.1M
In vivo reagents to identify functional noncoding sequences in the TCF7L2 locusR21DK078871 · NIDDK · UNIVERSITY OF CHICAGO · PI NOBREGA, MARCELO A. · 2007 to 2008
$417k
NHGRI NIH HHS HG004428NHGRI NIH HHS R01 HG004428NIDDK NIH HHS DK020595NIDDK NIH HHS DK078871NIDDK NIH HHS P30 DK020595NIDDK NIH HHS P60 DK020595NIDDK NIH HHS R01 DK093972NIDDK NIH HHS R21 DK078871NIGMS NIH HHS T32 GM007197
6 · The paper itself

Abstract

aims/hypothesisRecent functional characterisations of genome-wide association study (GWAS) loci suggest that cis-regulatory variation may be a common paradigm for complex disease susceptibility. Several studies point to a similar mechanism at the transcription factor 7-like 2 (TCF7L2) GWAS locus for type 2 diabetes. To address this possibility, we carried out an in vitro scan of this diabetes-associated locus to fine-map cis-regulatory sequences within this genomic interval.

methodsA systematic cell-based enhancer strategy was employed to interrogate all sequences within the 92 kb type-2-diabetes-association interval for cis-regulatory activity in a panel of cell lines (HCT-116, Neuro-2a, C2C12, U2OS, MIN6 and HepG2). We further evaluated chromatin state at a subset of these regions in HCT-116 and U2OS cells and examined allelic-specific enhancer properties at the type-2-diabetes-associated single nucleotide polymorphism (SNP) rs7903146.

resultsIn total, we assigned cis-regulatory activity to approximately 30% (9/28) of constructs tested. Notably, a subset of enhancers was active across multiple cell lines and overlapped with key epigenetic markers suggestive of cis-regulatory sequences. We further replicated the allelic-specific properties for SNP rs7903146 in pancreatic beta cells and additionally demonstrate identical allelic-specific enhancer effects in other cell lines.

conclusionsThese results provide a detailed map of cis-regulatory elements within the TCF7L2 GWAS locus and support the hypothesis of cis-regulatory variation leading to type 2 diabetes predisposition. The detection of allelic-specific effects for SNP rs7903146 in multiple cell lines further alludes to the likelihood of a peripheral defect in disease aetiology.

Indexed as

Chromatin Assembly and DisassemblyEnhancer Elements, GeneticGene Expression RegulationPolymorphism, Single NucleotideAllelesAnimalsBiomarkersCell LineDiabetes Mellitus, Type 2Epigenesis, GeneticGenetic LociGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansInsulin-Secreting CellsMiceBiomarkersRecombinant ProteinsTCF7L2 protein, humanTranscription Factor 7-Like 2 Protein

Identifiers

PMID23011354
PMCPMC3525810
OpenAlexW1990635533

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.